Aoxing Pharmaceutical Company Inc (AOXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2016 | 06-2015 | 06-2014 | 06-2013 | 06-2012 | |
| Sales | 32,330 | 25,481 | 12,739 | 10,830 | 8,134 |
| Cost of Goods | 7,776 | 5,689 | 6,926 | 4,562 | 3,234 |
| Gross Profit | 24,554 | 19,792 | 5,814 | 6,268 | 4,900 |
| Operating Expenses | 19,102 | 11,786 | 10,074 | 21,051 | 19,683 |
| Operating Income | 6,228 | 8,696 | -3,335 | -14,222 | -14,549 |
| Interest Expense | 3,457 | 5,768 | 5,195 | 2,987 | 1,863 |
| Other Income | 114 | 187 | -105 | -83 | 534 |
| Pre-tax Income | 2,886 | 3,114 | -8,634 | -17,291 | -15,878 |
| Income Tax | 642 | -2,704 | N/A | N/A | N/A |
| Net Income Continuous | 2,244 | 5,819 | -8,634 | -17,291 | -15,878 |
| Minority Interests | 182 | 324 | -419 | -486 | -57 |
| Net Income | $2,061 | $5,495 | $-8,216 | $-16,804 | $-15,820 |
| EPS Basic Total Ops | 0.03 | 0.09 | -0.16 | -0.34 | -0.32 |
| EPS Basic Continuous Ops | 0.03 | 0.09 | -0.17 | -0.35 | -0.32 |
| EPS Diluted Total Ops | 0.03 | 0.09 | -0.16 | -0.34 | -0.32 |
| EPS Diluted Continuous Ops | 0.03 | 0.09 | -0.17 | -0.35 | -0.32 |
| EPS Diluted Before Non-Recurring Items | 0.03 | 0.09 | -0.16 | -0.20 | -0.05 |
| EBITDA(a) | $7,254 | $9,362 | $-2,345 | $-12,490 | $-13,469 |